NCT02135640View on ClinicalTrials.gov

China HVT Safety, PK, PD

PHASE1CompletedINTERVENTIONAL

Enrollment

64

Participants

Timeline

Start Date

July 17, 2014

Primary Completion Date

February 17, 2015

Study Completion Date

February 17, 2015

Conditions

Osteoporosis

Interventions

DRUG

denosumab 60mg

solution

DRUG

denosumab 120 mg

solution

DRUG

placebo

solution

Trial Locations (1)

200030

GSK Investigational Site, Shanghai

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY